neostem inc
NeoStem & CBMG Embark On Phase II Trial For Liver Cancer
The Phase II trial for patients with late stage liver cancer will examine the effectiveness of a dendritic cell-based therapy.
The Phase II trial for patients with late stage liver cancer will examine the effectiveness of a dendritic cell-based therapy.
